Back to top
more

Amedisys (AMED)

(Delayed Data from NSDQ)

$96.12 USD

96.12
370,120

+0.08 (0.08%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $96.15 +0.03 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Sanghamitra Saha headshot

5 Top-Ranked Stocks Empowered by DuPont Analysis

Have more faith in DuPont analysis than simple ROE calculation and bet on these five stocks.

Amedisys Rides on New Buyouts, Strength in Personal Care Arm

Amedisys' (AMED) recently-integrated Personal Care segment is attaining stability and living up to expectation.

Sumit Singh headshot

Bet on These 5 Stocks With Exciting Interest Coverage Ratio

Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.

Amedisys (AMED) Upgraded to Strong Buy: Here's What You Should Know

Amedisys (AMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR

Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR

Top Ranked Momentum Stocks to Buy for June 21st

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 21st.

Sanghamitra Saha headshot

Bet Big on DuPont Analysis With These Top 5 Picks

Do you have more faith in DuPont analysis than a simple ROE calculation? Bet on these five stocks then.

Here is Why Growth Investors Should Buy Amedisys (AMED) Now

Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks.com featured highlights include: Intuit, Insperity, Amedisys, Pioneer Natural and Century Casinos

Zacks.com featured highlights include: Intuit, Insperity, Amedisys, Pioneer Natural and Century Casinos

Sumit Singh headshot

5 Stocks With Impressive Interest Coverage Ratio to Buy Now

Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.

Zacks.com featured highlights include: Shoe Carnival, Ulta, Amedisys, NVR and EMCOR

Zacks.com featured highlights include: Shoe Carnival, Ulta, Amedisys, NVR and EMCOR

3 Reasons Why Growth Investors Shouldn't Overlook Amedisys (AMED)

Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Amedisys (AMED) Down 9.3% Since Last Earnings Report: Can It Rebound?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sanghamitra Saha headshot

Is Trade War Scaring You? Buy 5 DuPont-Tested Quality Stocks

Bet on five top-ranked stocks with higher ROE derived the DuPont way.

Here is Why Growth Investors Should Buy Amedisys (AMED) Now

Amedisys (AMED) could produce exceptional returns because of its solid growth attributes.

Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems

Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems

Swayta Shah headshot

5 Stocks With Upgraded Broker Ratings Worth Betting on Now

Brokers have more understanding of fundamentals of a company, and also about the overall economy. So, following broker advice is a wise decision.

Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1

At Home Health and Hospice divisions, Amedisys (AMED) witnesses solid year-over-year growth in Medicare and non-Medicare revenues.

Amedisys (AMED) Upgraded to Buy: Here's What You Should Know

Amedisys (AMED) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks.com featured highlights include: Raytheon, Otter, Amedysis, Tutor and DMC

Zacks.com featured highlights include: Raytheon, Otter, Amedysis, Tutor and DMC

Amedisys (AMED) is an Incredible Growth Stock: 3 Reasons Why

Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Buy These 5 Low Leverage Stocks to Avoid Huge Losses

Companies with large debt loads are more vulnerable during economic downturns and can even go bankrupt in the worst-case scenario

Sumit Singh headshot

These 5 Stocks Boast Impressive Interest Coverage Ratio

Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.

Amedisys (AMED) Reports Next Week: Wall Street Expects Earnings Growth

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Edwards Lifesciences Takes Over CAS Medical Systems for $100M

This CASMED acquisition is expected to strengthen Edwards Lifesciences' (EW) critical care portfolio and expand its footprint in the smart monitoring technology market.